PENNINGTON, N.J. and SAN DIEGO, Feb. 22, 2022 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the body\'s immune system to target and attack...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]nancial-officer-301488010.html